| Bos taurus |
Adenosine deaminase |
Stability |
nan |
% |
10.1021/acs.jmedchem.2c01348 |
| Candida albicans (strain WO-1) (Yeast) |
ATP-dependent molecular chaperone HSP82 |
EC50 |
150000.0 |
nM |
None |
| Chlorocebus sabaeus |
Vero |
IC50 |
0.5 |
nM |
10.1021/jm981132u |
| Coxsackievirus B4 |
Coxsackievirus B4 |
MIC |
100.0 |
ug.mL-1 |
10.1021/jm00102a010 |
| Hepacivirus hominis |
Hepatitis C virus |
EC50 |
70000.0 |
nM |
10.1016/j.bmc.2014.08.024 |
| Hepatitis C virus |
Hepatitis C virus NS5B RNA-dependent RNA polymerase |
EC50 |
46000.0 |
nM |
10.1021/jm030424e |
| Hepatitis C virus |
Hepatitis C virus NS5B RNA-dependent RNA polymerase |
IC50 |
22000.0 |
nM |
10.1021/jm030424e |
| Homo sapiens |
Adenosine deaminase |
Drug metabolism |
nan |
None |
10.1021/jm401530a |
| Homo sapiens |
BXPC-3 |
Imax |
22.0 |
% |
10.1021/acs.jmedchem.2c01348 |
| Homo sapiens |
BXPC-3 |
LC50 |
198000.0 |
nM |
10.1021/acs.jmedchem.2c01348 |
| Homo sapiens |
CCRF-CEM |
FC |
2.0 |
None |
10.1021/acs.jmedchem.2c01348 |
| Homo sapiens |
CCRF-CEM |
FC |
16.0 |
None |
10.1021/acs.jmedchem.2c01348 |
| Homo sapiens |
CCRF-CEM |
Imax |
12.0 |
% |
10.1021/acs.jmedchem.2c01348 |
| Homo sapiens |
CCRF-CEM |
LC50 |
198000.0 |
nM |
10.1021/acs.jmedchem.2c01348 |
| Homo sapiens |
HEL 92.1.7 |
Imax |
88.0 |
% |
10.1021/acs.jmedchem.2c01348 |
| Homo sapiens |
HEL 92.1.7 |
LC50 |
68900.0 |
nM |
10.1021/acs.jmedchem.2c01348 |
| Homo sapiens |
HepG2 |
IC50 |
100000.0 |
nM |
10.6019/CHEMBL3430912 |
| Homo sapiens |
HepG2 |
Imax |
66.0 |
% |
10.1021/acs.jmedchem.2c01348 |
| Homo sapiens |
HepG2 |
LC50 |
142470.0 |
nM |
10.1021/acs.jmedchem.2c01348 |
| Homo sapiens |
Histone deacetylase 6 |
Inhibition |
-9.63 |
% |
10.6019/CHEMBL4808148 |
| Homo sapiens |
Histone deacetylase 6 |
Inhibition |
4.37 |
% |
10.6019/CHEMBL4808148 |
| Homo sapiens |
HL-60 |
Imax |
88.0 |
% |
10.1021/acs.jmedchem.2c01348 |
| Homo sapiens |
HL-60 |
LC50 |
76840.0 |
nM |
10.1021/acs.jmedchem.2c01348 |
| Homo sapiens |
HT-29 |
Imax |
44.0 |
% |
10.1021/acs.jmedchem.2c01348 |
| Homo sapiens |
HT-29 |
LC50 |
198000.0 |
nM |
10.1021/acs.jmedchem.2c01348 |
| Homo sapiens |
Jurkat |
Imax |
20.0 |
% |
10.1021/acs.jmedchem.2c01348 |
| Homo sapiens |
Jurkat |
LC50 |
198000.0 |
nM |
10.1021/acs.jmedchem.2c01348 |
| Homo sapiens |
K562 |
Imax |
88.0 |
% |
10.1021/acs.jmedchem.2c01348 |
| Homo sapiens |
K562 |
LC50 |
59310.0 |
nM |
10.1021/acs.jmedchem.2c01348 |
| Homo sapiens |
KG-1 |
Imax |
78.0 |
% |
10.1021/acs.jmedchem.2c01348 |
| Homo sapiens |
KG-1 |
LC50 |
70820.0 |
nM |
10.1021/acs.jmedchem.2c01348 |
| Homo sapiens |
MCF7 |
Imax |
78.0 |
% |
10.1021/acs.jmedchem.2c01348 |
| Homo sapiens |
MCF7 |
LC50 |
34230.0 |
nM |
10.1021/acs.jmedchem.2c01348 |
| Homo sapiens |
MIA PaCa-2 |
Imax |
35.0 |
% |
10.1021/acs.jmedchem.2c01348 |
| Homo sapiens |
MIA PaCa-2 |
LC50 |
198000.0 |
nM |
10.1021/acs.jmedchem.2c01348 |
| Homo sapiens |
MOLT-4 |
IC50 |
100.0 |
nM |
10.1021/jm401530a |
| Homo sapiens |
MOLT-4 |
IC50 |
100000.0 |
nM |
10.1021/jm401530a |
| Homo sapiens |
MOLT-4 |
Imax |
52.0 |
% |
10.1021/acs.jmedchem.2c01348 |
| Homo sapiens |
MOLT-4 |
LC50 |
151920.0 |
nM |
10.1021/acs.jmedchem.2c01348 |
| Homo sapiens |
MT4 |
CD50 |
45.0 |
uM |
10.1021/jm00118a033 |
| Homo sapiens |
MT4 |
Selectivity index |
0.5 |
None |
10.1021/jm00118a033 |
| Homo sapiens |
MV4-11 |
Imax |
1.0 |
% |
10.1021/acs.jmedchem.2c01348 |
| Homo sapiens |
MV4-11 |
LC50 |
198000.0 |
nM |
10.1021/acs.jmedchem.2c01348 |
| Homo sapiens |
NCI-H929 |
Imax |
24.0 |
% |
10.1021/acs.jmedchem.2c01348 |
| Homo sapiens |
NCI-H929 |
LC50 |
198000.0 |
nM |
10.1021/acs.jmedchem.2c01348 |
| Homo sapiens |
RL |
FC |
2.0 |
None |
10.1021/acs.jmedchem.2c01348 |
| Homo sapiens |
RL |
Imax |
17.0 |
% |
10.1021/acs.jmedchem.2c01348 |
| Homo sapiens |
RL |
LC50 |
198000.0 |
nM |
10.1021/acs.jmedchem.2c01348 |
| Homo sapiens |
RPMI-8226 |
Imax |
1.0 |
% |
10.1021/acs.jmedchem.2c01348 |
| Homo sapiens |
RPMI-8226 |
LC50 |
198000.0 |
nM |
10.1021/acs.jmedchem.2c01348 |
| Homo sapiens |
SW-620 |
Imax |
10.0 |
% |
10.1021/acs.jmedchem.2c01348 |
| Homo sapiens |
SW-620 |
LC50 |
198000.0 |
nM |
10.1021/acs.jmedchem.2c01348 |
| Homo sapiens |
THP-1 |
Imax |
-3.0 |
% |
10.1021/acs.jmedchem.2c01348 |
| Homo sapiens |
THP-1 |
LC50 |
198000.0 |
nM |
10.1021/acs.jmedchem.2c01348 |
| Homo sapiens |
Tyrosyl-DNA phosphodiesterase 1 |
Potency |
7307.8 |
nM |
None |
| Homo sapiens |
Tyrosyl-DNA phosphodiesterase 1 |
Potency |
8199.5 |
nM |
None |
| Homo sapiens |
Z-138 |
Imax |
95.0 |
% |
10.1021/acs.jmedchem.2c01348 |
| Homo sapiens |
Z-138 |
LC50 |
12150.0 |
nM |
10.1021/acs.jmedchem.2c01348 |
| Human alphaherpesvirus 1 |
Human alphaherpesvirus 1 |
MIC |
40.0 |
ug.mL-1 |
10.1021/jm00102a010 |
| Human alphaherpesvirus 2 |
Human alphaherpesvirus 2 |
MIC |
40.0 |
ug.mL-1 |
10.1021/jm00102a010 |
| Human immunodeficiency virus 1 |
Human immunodeficiency virus 1 |
ED50 |
50.0 |
uM |
10.1021/jm00118a033 |
| Human immunodeficiency virus 1 |
Human immunodeficiency virus 1 |
MIC |
4.0 |
ug.mL-1 |
10.1021/jm00102a010 |
| Human respirovirus 3 |
Human respirovirus 3 |
MIC |
100.0 |
ug.mL-1 |
10.1021/jm00102a010 |
| Leishmania donovani |
Leishmania donovani |
IC50 |
50118.72 |
nM |
10.6019/CHEMBL3430912 |
| Mammalian orthoreovirus 1 |
Mammalian orthoreovirus 1 |
MIC |
100.0 |
ug.mL-1 |
10.1021/jm00102a010 |
| Mus musculus |
L929 |
IC50 |
28700.0 |
nM |
10.1021/jm401530a |
| Mus musculus |
Mus musculus |
AUC |
4824.0 |
ng.hr.mL-1 |
10.1016/j.ejmech.2008.05.013 |
| Mus musculus |
Mus musculus |
Cmax |
10100.0 |
nM |
10.1016/j.ejmech.2008.05.013 |
| Mus musculus |
Mus musculus |
T1/2 |
2.1 |
hr |
10.1016/j.ejmech.2008.05.013 |
| Mus musculus |
Mus musculus |
Tmax |
1.5 |
hr |
10.1016/j.ejmech.2008.05.013 |
| Mus musculus |
NIH3T3 |
IC50 |
50118.72 |
nM |
10.6019/CHEMBL3430912 |
| Mus musculus |
Toll-like receptor 4 |
Inhibition |
nan |
% |
10.1021/acs.jnatprod.5b00573 |
| Mus musculus |
Transcription factor p65 |
Inhibition |
nan |
% |
10.1016/j.bmc.2012.10.047 |
| Plasmodium falciparum |
Plasmodium falciparum |
IC50 |
4.5 |
ug.mL-1 |
10.1021/np0401415 |
| Poliovirus 1 |
Poliovirus 1 |
MIC |
100.0 |
ug.mL-1 |
10.1021/jm00102a010 |
| Rattus norvegicus |
Adenosine A1 receptor |
Ki |
7120.0 |
nM |
10.1021/jm00020a014 |
| Rattus norvegicus |
Adenosine A1 receptor |
Ki |
7120.0 |
nM |
10.1021/jm970176k |
| Rattus norvegicus |
Adenosine A1 receptor |
Ki |
15200.0 |
nM |
10.1021/jm00020a014 |
| Rattus norvegicus |
Adenosine A1 receptor |
Ki |
15200.0 |
nM |
10.1021/jm970176k |
| Rattus norvegicus |
Adenosine A1 receptor |
Ratio |
2.1 |
None |
10.1021/jm970176k |
| Rattus norvegicus |
Rattus norvegicus |
GTP shift |
2.1 |
None |
10.1021/jm00020a014 |
| Saccharomyces cerevisiae S288c |
Mitochondrial import inner membrane translocase subunit TIM23 |
IC50 |
14000.0 |
nM |
None |
| Semliki Forest virus |
Semliki Forest virus |
MIC |
100.0 |
ug.mL-1 |
10.1021/jm00102a010 |
| Severe acute respiratory syndrome coronavirus 2 |
Replicase polyprotein 1ab |
Inhibition |
16.8 |
% |
10.6019/CHEMBL4495564 |
| Severe acute respiratory syndrome coronavirus 2 |
Replicase polyprotein 1ab |
Inhibition |
19.48 |
% |
10.6019/CHEMBL4495564 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
IC50 |
19952.62 |
nM |
10.6019/CHEMBL4651402 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
IC50 |
20000.0 |
nM |
10.6019/CHEMBL4651402 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
Inhibition |
0.0 |
% |
10.6019/CHEMBL4495565 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
Inhibition |
0.03 |
% |
10.6019/CHEMBL4495565 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
Inhibition |
14.13 |
% |
10.21203/rs.3.rs-23951/v1 |
| Sindbis virus |
Sindbis virus |
MIC |
100.0 |
ug.mL-1 |
10.1021/jm00102a010 |
| Trichomonas vaginalis |
Trichomonas vaginalis |
GI |
94.1 |
% |
10.1016/j.bmcl.2012.03.087 |
| Trypanosoma brucei |
Trypanosoma brucei |
IC50 |
1.2 |
nM |
10.1021/jm401530a |
| Trypanosoma brucei |
Trypanosoma brucei |
IC50 |
32.0 |
nM |
10.1021/jm401530a |
| Trypanosoma brucei |
Trypanosoma brucei |
IC50 |
42.0 |
nM |
10.1021/jm401530a |
| Trypanosoma brucei brucei |
Trypanosoma brucei brucei |
Activity |
nan |
None |
10.1021/jm401530a |
| Trypanosoma brucei brucei |
Trypanosoma brucei brucei |
IC50 |
10.0 |
nM |
10.6019/CHEMBL3430912 |
| Trypanosoma brucei brucei |
Trypanosoma brucei brucei |
IC50 |
12.59 |
nM |
10.6019/CHEMBL3430912 |
| Trypanosoma brucei brucei |
Trypanosoma brucei brucei |
IC50 |
30.0 |
nM |
10.1021/jm401530a |
| Trypanosoma cruzi |
Trypanosoma cruzi |
EC50 |
2510.0 |
nM |
10.1021/acs.jmedchem.8b00999 |
| Trypanosoma cruzi |
Trypanosoma cruzi |
IC50 |
1122.02 |
nM |
10.6019/CHEMBL3430912 |
| Trypanosoma cruzi |
Trypanosoma cruzi |
IC50 |
1258.93 |
nM |
10.6019/CHEMBL3430912 |
| Trypanosoma cruzi |
Trypanosoma cruzi |
IC50 |
1995.26 |
nM |
10.6019/CHEMBL3430912 |
| Trypanosoma cruzi |
Trypanosoma cruzi |
IC50 |
5011.87 |
nM |
10.6019/CHEMBL3430912 |
| Trypanosoma cruzi (strain CL Brener) |
Sterol 14-alpha demethylase |
IC50 |
100000.0 |
nM |
10.6019/CHEMBL3430912 |
| Vaccinia virus |
Vaccinia virus |
MIC |
100.0 |
ug.mL-1 |
10.1021/jm00102a010 |
| Vesicular stomatitis virus |
Vesicular stomatitis virus |
MIC |
40.0 |
ug.mL-1 |
10.1021/jm00102a010 |
| Vesicular stomatitis virus |
Vesicular stomatitis virus |
MIC |
100.0 |
ug.mL-1 |
10.1021/jm00102a010 |
| None |
ADMET |
Binding energy |
8.2 |
kCal mol-1 |
10.1021/jm00378a021 |
| None |
ADMET |
CC50 |
13000.0 |
nM |
10.1016/j.bmc.2014.08.024 |
| None |
ADMET |
FC |
19.0 |
None |
10.1021/acs.jmedchem.2c01348 |
| None |
ADMET |
FC |
38.0 |
None |
10.1021/acs.jmedchem.2c01348 |
| None |
ADMET |
Ratio EC50 |
25.0 |
None |
10.1021/acs.jmedchem.8b00999 |
| None |
ADMET |
Stability |
42.1 |
% |
10.1021/acs.jmedchem.2c01348 |
| None |
ADMET |
Stability |
nan |
% |
10.1021/acs.jmedchem.2c01348 |
| None |
ADMET |
T1/2 |
0.4167 |
hr |
10.1021/acs.jmedchem.2c01348 |
| None |
ADMET |
T1/2 |
1.033 |
hr |
10.1021/acs.jmedchem.2c01348 |
| None |
ADMET |
T1/2 |
4.2 |
hr |
10.1021/acs.jmedchem.2c01348 |
| None |
Hepatotoxicity |
Hepatotoxicity |
nan |
None |
10.1021/tx900326k |
| None |
No relevant target |
Drug metabolism |
0.012 |
L/mol/min |
10.1021/acs.jmedchem.1c00790 |
| None |
Unchecked |
Activity |
nan |
None |
10.1021/acs.jmedchem.2c01348 |
| None |
Unchecked |
EC50 |
4100.0 |
nM |
None |
| None |
Unchecked |
EC50 |
64000.0 |
nM |
10.1021/acs.jmedchem.8b00999 |
| None |
Unchecked |
EC50 |
150000.0 |
nM |
None |
| None |
Unchecked |
Imax |
2.0 |
% |
10.1021/acs.jmedchem.2c01348 |
| None |
Unchecked |
Ki |
180.0 |
nM |
10.1021/jm401530a |
| None |
Unchecked |
LC50 |
198000.0 |
nM |
10.1021/acs.jmedchem.2c01348 |
| None |
Unchecked |
Potency |
4466.8 |
nM |
None |
| None |
Unchecked |
Potency |
10000.0 |
nM |
None |
| None |
Unchecked |
Potency |
44668.4 |
nM |
None |
| None |
Unchecked |
Ratio CC50/EC50 |
0.19 |
None |
10.1016/j.bmc.2014.08.024 |